Bryn Pharma
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7101 Millstone Ridge Ct, Raleigh, North ...Phone Number
(310) 869-2204Website
www.brynpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Bryn Pharma
Bryn Pharma is dedicated to developing an affordable, needle-free epinephrine nasal spray designed for individuals at risk of anaphylaxis. Their mission is to provide a portable and easy-to-use solution that does not require special medical training, addressing common barriers that prevent patients from successfully managing their condition. Founded by patients affected by anaphylaxis, Bryn Pharma emphasizes a patient-centered approach in its innovation. Their product, NDS1C, aims to revolutionize emergency epinephrine delivery and improve treatment accessibility.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bryn Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Bryn Pharma
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Bryn Pharma launches new products
Funding: Get notified immidiatlly once Bryn Pharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Bryn Pharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Bryn Pharma recently announced quarterly report
Check out if Bryn Pharma is spiking on competitors!
Bryn Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Bryn Pharma had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Bryn Pharma
Compare insights from companies similar to Bryn Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Bryn Pharma
<$5M
1-10
Private
$26M
2017
N/A
Company Profile Activity
Activity Insights
Bryn Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bryn Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bryn Pharma.
Bryn Pharma financials insights
Gather financial insights about Bryn Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Private Equity
$26M
Bryn Pharma Tech Stack
A closer look at the technologies used by Bryn Pharma
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Moves, Lateral Move
Left Company
Executive Move
Left Company
Executive Move
New Hire
Management Move
Bryn Pharma News & Media
Bryn Pharma Appoints Joshua Ziel as Chief Executive Officer
LEBANON, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Bryn Pharma, LLC, a privately held pharmaceutical company dedicated to finding a novel and convenient way for patients and caregivers to treat anaphylaxis, today announced that Joshua Ziel, Ph.D., has been appointed Chief Executive Officer (CEO) and member of the Board of Directors. Sandy Loreaux is stepping down as CEO for family-related reasons but will remain on Bryn Pharma’s Board of Directors to continue to help guideBryn Pharma to Present Positive Results from Three New Analyses Further Supporting Use of Its Epinephrine Nasal Spray in Adults at the 2024 AAAAI Annual Meeting
~ Late-breaking presentation demonstrates that a repeat dose of NDS1C epinephrine nasal spray within five minutes safely increases epinephrine absorption by approximately 50 percent compared with a single dose ~ ~ Additionally, new pooled analyses will be presented showing an enhanced...Positive Results from Pivotal Study for Bryn Pharma's Investigational Epinephrine Nasal Spray Published in the Journal of Allergy and Clinical Immunology: Global
~ First study to demonstrate rapid and sustained absorption of NDS1C epinephrine nasal spray compared to epinephrine intramuscular autoinjector, while offering higher and more sustained therapeutic plasma levels ~ ~ Study also found that NDS1C was safe and generally well-tolerated,...Bryn Pharma to Present Positive Clinical Data Supporting Use of Its Epinephrine Nasal Spray in Adults with or without Congestion at 2023 ACAAI Annual Meeting
~ Results showed that NDS1C provides enhanced absorption in adults with or without congestion compared to current first-line intramuscular epinephrine and autoinjector administered treatments ~ ~ The study also found that NDS1C was safe and generally well-tolerated; if approved, NDS1C may...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bryn Pharma
Sign Up For FreeTo access detailed company insights
Bryn Pharma is dedicated to developing an affordable, needle-free epinephrine nasal spray designed for individuals at risk of anaphylaxis. Their mission is to provide a portable and easy-to-use solution that does not require special medical training, addressing common barriers that prevent patients from successfully managing their condition. Founde... Read More
